The prescribing patterns have changed over the years, and the concomitance factor used will not be updated for the emergence of new NADs and combinations, with the increase in polytherapy and the trend towards the introduction of increasingly earlier insulin use for the control of hyperglycemia and the prevention of future complications. Here, INS is linked to Hyperglycemia.